1. Home
  2. NKTR vs BVFL Comparison

NKTR vs BVFL Comparison

Compare NKTR & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • BVFL
  • Stock Information
  • Founded
  • NKTR 1990
  • BVFL 1873
  • Country
  • NKTR United States
  • BVFL United States
  • Employees
  • NKTR N/A
  • BVFL N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • BVFL Savings Institutions
  • Sector
  • NKTR Health Care
  • BVFL Finance
  • Exchange
  • NKTR Nasdaq
  • BVFL Nasdaq
  • Market Cap
  • NKTR 247.9M
  • BVFL 205.3M
  • IPO Year
  • NKTR 1994
  • BVFL N/A
  • Fundamental
  • Price
  • NKTR $0.90
  • BVFL $17.14
  • Analyst Decision
  • NKTR Strong Buy
  • BVFL
  • Analyst Count
  • NKTR 5
  • BVFL 0
  • Target Price
  • NKTR $4.50
  • BVFL N/A
  • AVG Volume (30 Days)
  • NKTR 1.5M
  • BVFL 31.0K
  • Earning Date
  • NKTR 03-03-2025
  • BVFL 01-28-2025
  • Dividend Yield
  • NKTR N/A
  • BVFL N/A
  • EPS Growth
  • NKTR N/A
  • BVFL N/A
  • EPS
  • NKTR N/A
  • BVFL 1.20
  • Revenue
  • NKTR $93,137,000.00
  • BVFL $38,028,000.00
  • Revenue This Year
  • NKTR $12.85
  • BVFL N/A
  • Revenue Next Year
  • NKTR N/A
  • BVFL N/A
  • P/E Ratio
  • NKTR N/A
  • BVFL $14.33
  • Revenue Growth
  • NKTR 5.53
  • BVFL 0.50
  • 52 Week Low
  • NKTR $0.50
  • BVFL $10.14
  • 52 Week High
  • NKTR $1.93
  • BVFL $18.19
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 40.16
  • BVFL 53.00
  • Support Level
  • NKTR $0.87
  • BVFL $16.54
  • Resistance Level
  • NKTR $0.94
  • BVFL $17.25
  • Average True Range (ATR)
  • NKTR 0.09
  • BVFL 0.31
  • MACD
  • NKTR -0.01
  • BVFL -0.03
  • Stochastic Oscillator
  • NKTR 15.63
  • BVFL 74.40

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. It offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, business checking as well as certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

Share on Social Networks: